Two Sigma Securities’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.1K Buy
+18,056
New +$23.1K ﹤0.01% 1366
2025
Q4
Sell
-15,584
Closed -$26.6K 1504
2025
Q3
$26.6K Buy
+15,584
New +$49.5K ﹤0.01% 1084
2024
Q4
Sell
-2,377
Closed -$64.7K 1791
2024
Q3
$64.7K Buy
+2,377
New +$74K ﹤0.01% 2337
2024
Q2
Sell
-594
Closed -$39.6K 3004
2024
Q1
$39.6K Sell
594
-230
-28% -$17.2K ﹤0.01% 2600
2023
Q4
$93.4K Buy
+824
New +$86.1K ﹤0.01% 2528
2023
Q3
Sell
-115
Closed -$42K 2955
2023
Q2
$42K Buy
+115
New +$51.9K ﹤0.01% 2419
2023
Q1
Sell
-108
Closed -$94.8K 2678
2022
Q4
$94.8K Buy
+108
New +$136K ﹤0.01% 2077
2022
Q2
Sell
-36
Closed -$56K 2231
2022
Q1
$56K Sell
36
-4
-10% -$5.4K ﹤0.01% 1862
2021
Q4
$72K Sell
40
-32
-44% -$85.6K ﹤0.01% 1218
2021
Q3
$238K Buy
+72
New +$252K 0.01% 1133
2020
Q3
Sell
-19
Closed -$6K 1308
2020
Q2
$6K Buy
+19
New +$4.77K ﹤0.01% 1325
2020
Q1
Sell
-18
Closed -$14K 1409
2019
Q4
$14K Buy
+18
New +$10.5K ﹤0.01% 2270

Other funds holding BNGO

Two Sigma Securities's BNGO Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Bionano Genomics (BNGO) in Q1 2026: 18,056 shares worth $21.1K. The stake represents ﹤0.01% of the portfolio and ranks #1366 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in BNGO as recently as Q3 2025.

Two Sigma Securities first reported a position in BNGO in Q4 2019 and has held it in 12 quarters since. The position peaked at $238K in Q3 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Two Sigma Securities held 18,056 shares of Bionano Genomics worth $21.1K as of Q1 2026.
  • Bionano Genomics was a new Two Sigma Securities position in Q1 2026.
  • Bionano Genomics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1366 holding.
  • Two Sigma Securities first reported a position in Bionano Genomics in Q4 2019 and has held it in 12 quarters since.
  • Two Sigma Securities's Bionano Genomics position peaked at $238K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.